Phoenix Financial’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$273K Buy
+1,423
New +$153K ﹤0.01% 458
2023
Q2
– Sell
-1,895
Closed -$277K – 350
2023
Q1
$277K Buy
+1,895
New +$313K 0.01% 247

Other funds holding MRNA

Phoenix Financial's MRNA Position: Q3 2026 in Review

Phoenix Financial opened a new position in Moderna (MRNA) in Q3 2026: 1,423 shares worth $273K. The stake represents ﹤0.01% of the portfolio and ranks #458 among its holdings. This is a return to the name: Phoenix Financial previously reported a position in MRNA as recently as Q1 2023.

Phoenix Financial first reported a position in MRNA in Q1 2023 and has held it in 2 quarters since. The position peaked at $277K in Q1 2023. 1,049 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Phoenix Financial held 1,423 shares of Moderna worth $273K as of Q3 2026.
  • Moderna was a new Phoenix Financial position in Q3 2026.
  • Moderna made up ﹤0.01% of Phoenix Financial's portfolio in Q3 2026, its #458 holding.
  • Phoenix Financial first reported a position in Moderna in Q1 2023 and has held it in 2 quarters since.
  • Phoenix Financial's Moderna position peaked at $277K in Q1 2023.
  • 1,049 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Phoenix Financial's 13F filing for Q3 2026, filed 9 Nov 2026.